Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

Toyos, MM

Toyos, MM (reprint author), Toyos Clin, Nashville, TN 37067 USA.

OPHTHALMOLOGY AND THERAPY, 2019; 8 (2): 261

Abstract

AimRandomized pilot study comparing clinical outcomes with bromfenac ophthalmic solution 0.07% versus nepafenac 0.3% ophthalmic suspension administere......

Full Text Link